Johannes Gutenberg-Universitat Mainz;Ganymed Pharmaceuticals AG
发明人:
Sahin, Ugur,Tureci, Ozlem,Koslowski, Michael,Walter, Korden,Woll, Stefan,Kreuzberg, Maria,Hubner, Bernd,Erdeljan, Michael,Weichel, Michael
申请号：
AU2012258087
公开号：
AU2012258087A1
申请日:
2012.04.20
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLDN6, including tumor- related diseases such as ovarian cancer, lung cancer, gastric cancer, breast cancer, hepatic cancer, pancreatic cancer, skin cancer, malignant melanoma, head and neck cancer, sarcoma, bile duct cancer, cancer of the urinary bladder, kidney cancer, colon cancer, placental choriocarcinoma, cervical cancer, testicular cancer, and uterine cancer.
